|
Featured Products
Comes with a syllabus
and CD or DVD
$99 (was $189)
Comes with a syllabus
and CD or DVD
$189 (was $219)
|
|
Contact Us
| |
Bariatric Physicians
2821 S. Parker Road
Ste. 625
Aurora, CO 80014
303.770.2526 | asbp.org
Staff
Laurie Traetow, CAE, CPA
Executive Director
laurie@asbp.org
Beth Amelon
Sponsorships & Exhibits Coordinator
beth@asbp.org
Carly Crosby
Meeting Planner & Executive Coordinator
carly@asbp.org
Marcie Gonzales
Receptionist
marcie@asbp.org
|
|
|
|
Obesity Medicine e-Weekly
|
Foundation
Call for proposals for OTF research grants
The Obesity Treatment Foundation (OTF) is now accepting letters of intent from candidates seeking a grant to fund research about obesity treatment. Letters of intent must be submitted by April 20, should be no longer than one page, and should describe the project, including specific aims and hypotheses. Applicants should submit their letters of intent with a cover page and an NIH-style biosketch or updated CV of the principal investigator. Learn more about OTF grants and the submission process. Questions? Contact OTF at research@asbp.org.
 Become a research mentor
Do you have experience collecting and analyzing patient data? Have you presented a poster at an ASBP conference? Has your research been published in a peer-reviewed journal? If so, OTF wants YOU to become a research mentor for new researchers in the field of obesity medicine. Contact research@asbp.org to indicate your interest in being a research mentor and serving as a resource for those who have questions about conducting research.
|
Resources
 The Obesity Treatment Foundation (OTF) helps keep you up to date on current obesity research! Each week, OTF publishes a brief overview of three recent studies so you can be in the know, even during your busiest days. Click the titles below to view the full articles, and please consider supporting OTF so we can continue to provide you with updates on the latest research.
Kim, D. D., et al. Diabetes Obesity Metabolism, 2015.
Inhibition of methionine aminopeptidase 2 (MetAP2) reduces fat synthesis and stimulates fat oxidation and lipolysis, producing weight loss in animal and clinical studies. Beloranib is a selective MetAP2 inhibitor that reduces food intake, body weight, fat content, and adipocyte size in rodent models of obesity. A 12-week controlled, double-blind efficacy study was conducted in 112 patients with obesity. The participants received a subcutaneous injection of 0.6, 1.2, or 2.4 milligrams (mg) of beloranib or a placebo twice weekly and were given no advice about diet or physical activity. After 12 weeks, beloranib resulted in dose-dependent progressive weight loss of -5.5, -6.9, and -10.9 kilograms (kg) for the 0.6, 1.2, and 2.4 mg beloranib doses, respectively, compared to -0.4 kg with the placebo. Weight loss was associated with reduced waist circumference and body fat mass as well as improvements in lipids, hsCRP, and blood pressure. This phase two study represents a potential new mechanism for producing clinically meaningful weight loss in patients with obesity.
Eslamparast, T., et al. World J Hepatol, 2015.
Individuals affected by obesity often have some degree of non-alcoholic fatty liver disease (NAFLD). NAFLD involves a range of conditions caused by lipid infiltration of the hepatocytes without significant amounts of alcohol use. Dietary supplements--including antioxidants, anti-inflammatory agents, insulin sensitizers, and lipid-lowering agents--may be beneficial in the treatment and prevention of NAFLD. This review explores the existing evidence on a number of dietary supplements considered to have properties that would protect the liver from NAFLD and the mechanisms for the protection they confer.
Management of obesity: Improvement of health care training and systems for prevention and care
Dietz, W. H., et al. Lancet, 2015.
Dr. William Dietz is speaking about effectively communicating with patients about obesity at the upcoming Obesity Medicine 2015 conference. He recently wrote a review article that discusses the management of obesity, education of health professionals, weight bias in medical settings, shortcomings in pediatric obesity care, and the need for institutional and community partnerships to address obesity. The article highlights the many challenges that we face in adequately addressing the obesity epidemic.
|
Advocacy
Advocacy Committee chairperson represents ASBP at OCC Advocacy Day
Dr. Carolynn Francavilla (pictured), ASBP Advocacy Committee chairperson, joined other leaders from the Obesity Care Continuum (OCC) for the OCC's monthly Advocacy Day on Capitol Hill, which took place March 2. Dr. Francavilla was joined by The Obesity Society's (TOS) executive director, Francesca Dea, the Obesity Action Coalition's (OAC) president, Joe Nadglowski, and OAC's board chairperson, Ted Kyle. Dr. Francavilla visited a number of key legislators in the Colorado congressional delegation and educated these offices about plans for the reintroduction of the Treat and Reduce Obesity Act (TROA). In addition to sitting down with staff in Senator Michael Bennet's (D-CO) office, Dr. Francavilla and OCC leaders visited the offices of Reps. Ed Perlmutter (D-CO), Diana DeGette (D-CO), Jared Polis (D-CO) and Mike Coffman (R-CO). The offices were all knowledgeable about the issue of obesity and the bill was well received. The next monthly OCC Advocacy Day will take place on April 27.
|
Education
 Early registration deadline for Obesity Medicine 2015 only 3 days away
Want more? Save the date for Overcoming Obesity 2015: Diagnose. Personalize. Treat. in Washington, D.C., from Sept. 30-Oct. 4, 2015.
 More Obesity Basic Medical Treatment courses scheduled this summer
Our winter season of Obesity Basic Medical Treatment courses is finished, but we're offering another series of courses this summer! Do you know anyone who wants to learn the basics of medical obesity treatment but doesn't know where to start? The Obesity Basic Medical Treatment (OBMT) course teaches physicians and health care providers who are brand new to the field of obesity medicine about the basic approaches to obesity treatment. Attendees can then decide whether or not to pursue further obesity medicine education or understand when to refer a patient to an obesity medicine clinician. Learn more about this course, or download a printable registration form. Online registration is also available for the following dates and cities.
|
|
|
|
|
Featured member benefit: Conference registration discount
Submit your narratives about the Obesity Algorithm® 
